Boston, MA 的 骨肉瘤 臨床試驗
9 項針對 骨肉瘤 的研究正在 Boston（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor
招募中2 期
- Dana-Farber Cancer Institute, Boston
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
招募中3 期
- Massachusetts General Hospital Cancer Center, Boston
- Dana-Farber Cancer Institute, Boston
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
招募中1/2 期
- Dana-Farber Cancer Institute, Boston
SPEARHEAD-3 Pediatric Study
招募中1/2 期
- Dana Farber Cancer Institute, Boston
NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)
招募中1/2 期
- Dana Farber Cancer Institute, Boston
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
招募中觀察性研究
- Dana-Farber Cancer Institute, Boston
Lu-TARGO (177Lu-TARGeted Osteosarcoma Therapy)
招募中1/2 期
- Dana Farber Cancer Institute, Boston
Atezolizumab and Cabozantinib for the Treatment of Adolescents and Young Adults With Recurrent or Metastatic Osteosarcoma, TACOS Study
招募中2 期
- Dana-Farber Cancer Institute, Boston
Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adolescents and Young Adults With Relapsed or Refractory Sarcomas
招募中1/2 期
- Boston Children's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
- Brigham and Women's Hospital, Boston
其他城市的 骨肉瘤 試驗
- Memphis, TN10 項研究
- Atlanta, GA10 項研究
- St. Louis, MO10 項研究
- Mountain View, CA8 項研究
- Chicago, IL7 項研究
- Los Angeles, CA7 項研究
- Birmingham, AL7 項研究
- Houston, TX7 項研究
- Tampa, FL6 項研究
- New York City, NY6 項研究
- Cincinnati, OH6 項研究
- Washington, DC6 項研究
Boston 的其他研究
- 乳癌111 項研究
- 非小細胞肺癌90 項研究
- 癌症（所有類型）86 項研究
- 大腸直腸癌63 項研究
- 轉移性癌症63 項研究
- 肺癌62 項研究
- 卵巢癌61 項研究
- 前列腺癌59 項研究
- 憂鬱症52 項研究
- 子宮內膜癌50 項研究
- 心臟衰竭44 項研究
- 急性髓系白血病44 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月5日。各研究自行設定資格標準；由研究團隊決定參與者資格。